openFDA Drug Safety Developer Guide¶
openFDA · Developer Guide
Working With Adverse Event Data After FDA's Move To Real-Time Reporting
Pharmacovigilance teams, health-tech products and research tools rely on FDA's adverse event data to spot safety signals early. Most of them reach it through openFDA, FDA's free public API, which turns millions of adverse event reports into searchable JSON. In 2026, the way FDA publishes that data changed, and openFDA has not kept pace.
How current is openFDA right now?
Values captured on October 29, 2026.
The Problem¶
What changedOn March 11, 2026, FDA launched the Adverse Event Monitoring System (AEMS), bringing drug, vaccine and other adverse event reporting onto one platform that FDA says publishes reports in real time. This followed FDA’s August 2025 move to publish drug adverse event reports daily. openFDA’s drug adverse event data still updates quarterly, with a lag of three months or more.
What breaksDashboards, research tools and AI products built on openFDA show data that’s months behind FDA’s own, and most never tell their users. When those adverse event counts are then read as evidence that a drug is risky, decisions end up resting on data that is both outdated and misunderstood.
Real exampleOn October 29, 2026, openFDA’s drug adverse event data reported a last update of July 30, 2026, and its most recent reports were received on June 30, 2026. The dataset holds over 20.6 million reports, but nothing from the four months since.
FDA says it now publishes in real time. openFDA's data ends at June 30, 2026.
Sources: RAPS on the AEMS launch, March 11, 2026; STAT on daily FAERS publication, August 22, 2025; openFDA meta.last_updated and a count of reports by receive date, captured October 29, 2026. "Real time" is FDA's own description of AEMS.
How This Guide Is Organised¶
The guide follows the Diátaxis framework, so each page does one job.
API responses captured from the live openFDA API on October 29, 2026. Licensed under CC BY 4.0. Written and maintained by Archana Panda, Senior Technical Content Writer. Not affiliated with FDA. openFDA data is unvalidated and must not be used to make decisions about medical care.